• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Intuitive Surgical to buy back $1B in shares from Goldman Sachs

Intuitive Surgical to buy back $1B in shares from Goldman Sachs

May 5, 2014 By Arezu Sarvestani

Intuitive Surgical to buy back $1B in shares from Goldman Sachs

California robot-assisted surgical systems maker Intuitive Surgical (NSDQ:ISRG) plans to buy back $1 billion worth of its common stock from Goldman Sachs under a new accelerated share repurchase program.

The company hopes the buyback will help reset the company’s valuation as its stock continues to slide. ISRG shares enjoyed a brief return to the mid $500s earlier this month, but have largely traded below $450 since last July. News of the repurchase sent shares up 1.2% today to $363.59 as of about 4 p.m. EST.

"Our decision to repurchase $1 billion in Intuitive Surgical stock on an accelerated basis reflects our long-term view of the value our company can bring to patients, surgeons and hospitals," president & CEO Gary Guthart said in prepared remarks.

Intuitive plans to retire the majority of newly repurchased shares within 2 weeks, with the remaining shares to be phased out by early November 2014.

The new mega-repurchasing program comes less than a year after Intuitive’s board OK’ed a $1.5 million share grab, including a $500 million accelerated buyback from Goldman Sachs.

Intuitive has for months been battling negative headlines about adverse events, recalls, FDA scrutiny, insurance group lawsuits, hospital marketing conflict-of-interest flaps and on. The downward spiral began last March when the American Congress of Obstetricians & Gynecologists released a statement questioning some of the marketed benefits of robot-assisted surgery. The study was accompanied by a letter from ACOG president Dr. James Breeden, who noted that the benefits of robot-assisted surgery may also be achieved through other minimally invasive methods that aren’t as costly as the high-tech procedure.

Intuitive has battled those notions with a slate of studies finding that robotic surgery reduces readmissions and costs associated with hysterectomy, bests open surgery for prostatectomy and more. Earlier this week the company highlighted a pair of studies touting robot-assisted lung surgery over either open or minimally invasive techniques. Nevertheless, sales have dwindled in recent quarters and shares have continued to slide.

Filed Under: News Well, Surgical Robotics, Wall Street Beat Tagged With: Goldman Sachs, Intuitive Surgical

More recent news

  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech
  • GE HealthCare launches new MRI scanner
  • HistoSonics earns first major reimbursement win for non-invasive histotripsy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy